Fig. 1From: Accounting for equity considerations in cost-effectiveness analysis: a systematic review of rotavirus vaccine in low- and middle-income countriesSteps of indicators’ mapping. *Norheim et al.’s criteria being: Severity, realization of potential, past health loss, socioeconomic status, area of living, gender, race, ethnicity, religion, sexual orientation, economic productivity, care for others and catastrophic health expenditureBack to article page